Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 3.16% vs -0.56% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 46.36% vs 21.97% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -8.93% vs 7.21% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -100.00% vs 2,100.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Harbin Gloria Pharmaceuticals Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 3.16% vs -0.56% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -11.11% vs 2.73% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 46.36% vs 21.97% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 83.25% vs -69.67% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -8.93% vs 7.21% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -4.27% vs 59.22% in Sep 2024
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






